Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MannKind Corp MNKD

Healthcare Biotechnology
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the... see more

Recent & Breaking News (NDAQ:MNKD)

Mid-Afternoon Market Update: Shoe Carnival Climbs On Upbeat Earnings; Genesco Shares Drop

Benzinga.com  August 31, 2017

18 Biggest Mid-Day Gainers For Thursday

Benzinga.com  August 31, 2017

Mid-Day Market Update: Crude Oil Up 2.5%; DryShips Shares Decline On News Of SEC Subpoena

Benzinga.com  August 31, 2017

Stocks Under Scanner in the Biotech Space -- Merrimack Pharma, MannKind, NeuroDerm, and Celsion

PR Newswire August 23, 2017

18 Biggest Mid-Day Gainers For Friday

Benzinga.com  August 11, 2017

MannKind Corporation Reports 2017 Second Quarter Financial Results

GlobeNewswire August 7, 2017

Investor Network: MannKind Corporation to Host Earnings Call

Accesswire August 7, 2017

MannKind and One Drop Partner to Launch the A-One Clinical Trial

PR Newswire August 7, 2017

MannKind Corporation to Hold 2017 Second Quarter Financial Results Conference Call on August 7, 2017

GlobeNewswire July 25, 2017

Steven Binder Joins MannKind as Chief Financial Officer

GlobeNewswire July 17, 2017

Patrick McCauley Joins MannKind as Chief Commercial Officer

GlobeNewswire July 12, 2017

MannKind Renegotiates Near-Term Maturities with Deerfield

GlobeNewswire June 29, 2017

MannKind Draws Remaining Funds under Mann Group Loan Arrangement

GlobeNewswire June 29, 2017

MannKind Draws Remaining Funds under Mann Group Loan Arrangement

GlobeNewswire June 28, 2017

Technical Snapshots for These Biotech Stocks -- Merrimack Pharma, MannKind, GlycoMimetics, and Radius Health

PR Newswire June 28, 2017

Watch These 7 Huge Put Purchases In Thursday Trade

Benzinga.com  June 15, 2017

MannKind Engages Locust Walk to Explore Strategic Options for MannKind’s Non-insulin Technosphere-based Pipeline Candidates

GlobeNewswire June 5, 2017

MannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil

GlobeNewswire May 31, 2017

MannKind Provides Update on Senior Management

GlobeNewswire May 30, 2017

Mid-Morning Market Update: Markets Open Lower; Macy's Profit Misses Expectations

Benzinga.com  May 11, 2017